ZAFIRLUKAST 20 MG TABLET

zafirlukast
$0.6654per EA

Strength

20 mg/1

NDC

64380018801

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ZAFIRLUKAST

Approval Type

New Drug (NDA)

FDA Application

NDA020547

On Market Since

8/1/2022

Pharmacological Classes

Cytochrome P450 2C9 Inhibitors
Leukotriene Receptor Antagonist
Leukotriene Receptor Antagonists

Price History

1W

0.0%

1M

+3.2%

3M

+1.2%

6M

-2.9%

1Y

+2.6%

3Y

-23.8%

5Y

N/A

All

-20.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.